The purpose of this study is to determine whether the addition of minocycline or placebo to
treatment as usual (TAU):
1. prevents the accumulation of negative symptoms and intellectual decline following a
first episode of non-affective psychosis; and
2. whether minocycline stabilizes the efficacy of antipsychotics.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Stanley Medical Research Institute
Collaborators:
Pakistan Institute of Learning and Living Pakistan Institute of Living and Learning Rawalpindi Medical College, Pakistan University of Sao Paulo